Literature DB >> 17110673

Discrepancy between neuroimaging findings and clinical phenotype in Alexander disease.

A Dinopoulos1, J R Gorospe, J C Egelhoff, K M Cecil, P Nicolaidou, P Morehart, T DeGrauw.   

Abstract

We present a case of infantile-onset Alexander disease (AD) with a novel glial fibrillary acidic protein mutation but without clinical evidence of neurologic deterioration. Brain MRI studies showed typical AD findings and increasing size of frontal cavitations. Serial proton MR spectroscopy demonstrated high levels of myo-inositol and lactic acid and decreasing levels of N-acetylaspartate. The degree of demyelination and the timing of the axonal degeneration may determine phenotypic severity of the disease. Conventional neuroimaging techniques cannot always predict the outcome.

Entities:  

Mesh:

Year:  2006        PMID: 17110673      PMCID: PMC7977192     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  19 in total

1.  Alexander disease: diagnosis with MR imaging.

Authors:  M S van der Knaap; S Naidu; S N Breiter; S Blaser; H Stroink; S Springer; J C Begeer; R van Coster; P G Barth; N H Thomas; J Valk; J M Powers
Journal:  AJNR Am J Neuroradiol       Date:  2001-03       Impact factor: 3.825

2.  Molecular findings in symptomatic and pre-symptomatic Alexander disease patients.

Authors:  J R Gorospe; S Naidu; A B Johnson; V Puri; G V Raymond; S D Jenkins; R C Pedersen; D Lewis; P Knowles; R Fernandez; D De Vivo; M S van der Knaap; A Messing; M Brenner; E P Hoffman
Journal:  Neurology       Date:  2002-05-28       Impact factor: 9.910

Review 3.  Alexander disease: new insights from genetics.

Authors:  A Messing; J E Goldman; A B Johnson; M Brenner
Journal:  J Neuropathol Exp Neurol       Date:  2001-06       Impact factor: 3.685

4.  MLC1: a novel protein in distal astroglial processes.

Authors:  P K Ilja Boor; Koen de Groot; Quinten Waisfisz; Wouter Kamphorst; Cees B M Oudejans; James M Powers; Jan C Pronk; Gert C Scheper; Marjo S van der Knaap
Journal:  J Neuropathol Exp Neurol       Date:  2005-05       Impact factor: 3.685

5.  Histopathology of an infantile-onset spongiform leukoencephalopathy with a discrepantly mild clinical course.

Authors:  M S van der Knaap; P G Barth; G F Vrensen; J Valk
Journal:  Acta Neuropathol       Date:  1996-08       Impact factor: 17.088

6.  Alexander's disease: further light-, and electron-microscopic observations.

Authors:  J Towfighi; R Young; J Sassani; J Ramer; D S Horoupian
Journal:  Acta Neuropathol       Date:  1983       Impact factor: 17.088

7.  Alexander's disease in a neurologically normal child: a case report.

Authors:  Scott O Guthrie; Edward M Burton; Paul Knowles; Robert Marshall
Journal:  Pediatr Radiol       Date:  2002-08-16

8.  Estimation of metabolite concentrations from localized in vivo proton NMR spectra.

Authors:  S W Provencher
Journal:  Magn Reson Med       Date:  1993-12       Impact factor: 4.668

9.  Alexander's disease in an adult: clinicopathologic study of a case and review of the literature.

Authors:  G Spalke; H D Mennel
Journal:  Clin Neuropathol       Date:  1982       Impact factor: 1.368

10.  A case of infantile Alexander disease with a milder phenotype and a novel GFAP mutation, L90P.

Authors:  Yoshiko Suzuki; Naomi Kanazawa; Junko Takenaka; Akihisa Okumura; Tamiko Negoro; Seiichi Tsujino
Journal:  Brain Dev       Date:  2004-04       Impact factor: 1.961

View more
  5 in total

Review 1.  GFAP and its role in Alexander disease.

Authors:  Roy A Quinlan; Michael Brenner; James E Goldman; Albee Messing
Journal:  Exp Cell Res       Date:  2007-04-06       Impact factor: 3.905

2.  Neonatal Alexander disease: MR imaging prenatal diagnosis.

Authors:  E Vázquez; A Macaya; N Mayolas; S Arévalo; M A Poca; G Enríquez
Journal:  AJNR Am J Neuroradiol       Date:  2008-07-24       Impact factor: 3.825

3.  Alteration of glial-neuronal metabolic interactions in a mouse model of Alexander disease.

Authors:  Tore Wergeland Meisingset; Øystein Risa; Michael Brenner; Albee Messing; Ursula Sonnewald
Journal:  Glia       Date:  2010-08       Impact factor: 7.452

4.  GFAP mutations, age at onset, and clinical subtypes in Alexander disease.

Authors:  M Prust; J Wang; H Morizono; A Messing; M Brenner; E Gordon; T Hartka; A Sokohl; R Schiffmann; H Gordish-Dressman; R Albin; H Amartino; K Brockman; A Dinopoulos; M T Dotti; D Fain; R Fernandez; J Ferreira; J Fleming; D Gill; M Griebel; H Heilstedt; P Kaplan; D Lewis; M Nakagawa; R Pedersen; A Reddy; Y Sawaishi; M Schneider; E Sherr; Y Takiyama; K Wakabayashi; J R Gorospe; A Vanderver
Journal:  Neurology       Date:  2011-09-14       Impact factor: 11.800

5.  Infantile Alexander disease: A rare leukodystrophy.

Authors:  K Jagadish Kumar; H Suryaprakash; V G Manjunath; S Harsha
Journal:  J Pediatr Neurosci       Date:  2012-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.